|
Mechanismprothrombin inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date15 Dec 2000 |
The ZBMUF trial: an open-label randomised study of the effects of ultra-filtration and high dose aprotinin on bivalirudin pharmacokinetics during and/or after cardiopulmonary bypass surgery - ZBMUF
100 Clinical Results associated with The Medicines Company UK Ltd.
0 Patents (Medical) associated with The Medicines Company UK Ltd.
100 Deals associated with The Medicines Company UK Ltd.
100 Translational Medicine associated with The Medicines Company UK Ltd.